![](https://in2pharma.com/wp-content/uploads/2019/11/Team_business-3370832_1280-300x200.jpg)
Europe
To prevent and mitigate shortages of critical medicines in the European Union, the EU commission has adopted a couple measures. These measures aim at ensuring adequate supply of medicines or managing medicine shortages. Examples of planned measures are:
- Regulatory flexibility
- A Union list of critical medicines
- Establishment of a voluntary EU solidarity mechanism
- …
In addition, the Commission plans to set up a “Critical Medicines Alliance” which will focus on a number of critical medicines with the highest risk of shortages and the greatest impact on health systems.